晚餐短期課程*

1月21日 (二) | 17:45~20:45

SC1: Best Practices for Biotherapeutic Discovery and Development
Instructor:
Wasfi AlAzzam, PhD, CSO, TechnoPharmaSphere (TPS)

SC2: The Safety of Immunotherapy and ADCs: How to Mitigate Risk and Adverse Effects
Instructors:
Rakesh Dixit, PhD, DABT, President & CEO, Bionavigen, LLC
George Octavian Badescu, PhD, Vice President, Scientific Affairs, Heidelberg Pharma AG

SC3: Structure-Based Optimization of Antibodies
Instructor:
Traian Sulea, PhD, Senior Research Officer, Human Health Therapeutics, Biotechnology Research Institute, National Research Council Canada

SC5: Protein Aggregation: Mechanism, Characterization, and Consequences
Instructors:
Thomas Laue, PhD, Professor Emeritus, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire
Kevin Mattison, PhD, Principal Scientist, Malvern Pananalytical, Inc.

SC6: Assembling an Effective Toolbox of Expression Systems to Support Your Drug Discovery Efforts
Instructor:
Richard Altman, MS, Field Application Scientist, Protein Expression, Biosciences Division, Life Sciences Solutions Group, Thermo Fisher Scientific
Additional Instructors to be Announced

Additional Short Course to be Announced


*Separate registration required

* 活動內容有可能不事先告知作更動及調整。

Choose your language
Chinese
Japanese
Korean
English






2020年會議節目和培訓研討會


免費電子郵件通知服務